Perampanel in the management of partial-onset seizures: a review of safety, efficacy, and patient acceptability

Perampanel (PER) is a novel antiepileptic drug recently introduced for the adjunctive treatment in epilepsy patients aged 12 years or older with partial-onset seizures with or without secondary generalization in the US and Europe. Its antiepileptic action is based on noncompetitive inhibition of pos...

Descripción completa

Detalles Bibliográficos
Autores principales: Schulze-Bonhage, Andreas, Hintz, Mandy
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2015
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4542413/
https://www.ncbi.nlm.nih.gov/pubmed/26316718
http://dx.doi.org/10.2147/PPA.S63951

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4542413/
https://www.ncbi.nlm.nih.gov/pubmed/26316718
http://dx.doi.org/10.2147/PPA.S63951

Ejemplares similares